靶向骨髓微环境治疗多发性骨髓瘤的进展.pdfVIP

·530 · 医学综述 20 10年 2 月第 16卷第 4 期 M edical R ecap itu late, Feb 2010 , Vol. 16 ,No. 4 [ 19 ] 　骆晓峰 ,刘庭波 ,陈志哲. RNA i技术逆转白血病多药耐药的研 [ J ]. J B iol Chem , 2008, 283 (44 ) : 2989729903. 究进展 [ J ]. 医学综述 , 2008, 14 ( 12) : 176 11764. [ 25 ] 　W ickram asinghe N S,M anavalan TT, Dougherty SM , et a l. E stradiol [ 20 ] 　X ia L , Zhang D , Du R , et a l. M iR 15b and m iR 16 modu late mu lti downregu lates m iR 2 1 exp ression and increases m iR 2 1 target gene drug resistance by targeting BCL2 in hum an gastric cancer cells exp ression in MCF7 b reast cancer cells [ J ]. N ucleic A cid s R e [ J ]. Int J Cancer, 2008, 123 (2) : 372379. search, 2009 , 37 ( 8) : 2584 2595. [ 2 1 ] 　Si ML , Zhu S, W u H , et a l. M iR 2 1m ediated tumor grow th [ J ]. [ 26 ] 　E lD eiry W S. The role of p 53 in chemosen sitivity and radiosen sitiv Oncogene, 2007 , 26 ( 19) : ity [ J ]. Oncogene, 2003 , 22 (47) : [ 22 ] 　A dam s BD , Fu rneaux H , W h ite BA. The m icroribonucleic acid [ 27 ] 　Fuj ita Y, Koj im a K, H am ada N , et a l. Effects of m iR 34 a on cell (m iRNA ) m iR 206 targets the hum an estrogen recep toralp ha ( ER grow th and chemoresistance in p rostate cancer PC3 cells [ J ]. B io alp ha) and rep resses ER alp ha m essenger RNA and p rotein exp res chem B iophys R es Commun , 2008, 377 ( 1) : 114 119. sion in b reast cancer cell lines[ J ]. Mol Endocrinol, 2007 , 2 1 ( 5) : [ 28 ] 　Yang H , KongW , H e L , et a l. M icroRNA exp ression p rofiling in hu 1132 1147. m an ovarian cancer: m iR 2 14 induces cell su rvival and cisp latin re [ 23 ] 　Zhao JJ , L in J , Yang H , et a l. M icroRNA 22 1/222 negatively re